Ruth J. Byrne

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Mpox clinical outcomes among people living with HIV and PrEP users: Findings from the MASH-1 multicentre cohort study.

Mpox clinical outcomes among people living with HIV and PrEP users: Findings from the MASH-1 multicentre cohort study.

Journal: HIV medicine
Published: March 05, 2026

The additive value of coronary calcium in identifying cardiovascular risk in ageing people with HIV.

The additive value of coronary calcium in identifying cardiovascular risk in ageing people with HIV.

Journal: AIDS (London, England)
Published: January 13, 2026

The effect of Biktarvy (B/F/TAF) on whole-body insulin sensitivity, lipid and endocrine profile in healthy volunteers.

The effect of Biktarvy (B/F/TAF) on whole-body insulin sensitivity, lipid and endocrine profile in healthy volunteers.

Journal: HIV medicine
Published: August 18, 2025

Necrotic skin reaction following the administration of intramuscular injections of long-acting cabotegravir/rilpivirine and alternatively-sourced testosterone.

Necrotic skin reaction following the administration of intramuscular injections of long-acting cabotegravir/rilpivirine and alternatively-sourced testosterone.

Journal: International journal of STD & AIDS
Published: June 24, 2025

Are we missing Mpox cases? Changes in clade IIb clinical phenotype in the post-vaccination era.

Are we missing Mpox cases? Changes in clade IIb clinical phenotype in the post-vaccination era.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 13, 2025

Perspectives of People With HIV on Implementing Long-acting Cabotegravir Plus Rilpivirine in Clinics and Community Settings in the United Kingdom: Results From the Antisexist, Antiracist, Antiageist Implementing Long-acting Novel Antiretrovirals Study.

Perspectives of People With HIV on Implementing Long-acting Cabotegravir Plus Rilpivirine in Clinics and Community Settings in the United Kingdom: Results From the Antisexist, Antiracist, Antiageist Implementing Long-acting Novel Antiretrovirals Study.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 15, 2024

Proviral HIV DNA sequencing to inform suitability for long-acting injectable cabotegravir/rilpivirine.

Proviral HIV DNA sequencing to inform suitability for long-acting injectable cabotegravir/rilpivirine.

Journal: AIDS (London, England)
Published: July 01, 2024

Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI-net).

Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI-net).

Journal: HIV medicine
Published: March 21, 2024

Switching Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide Fumarate (TAF) in Hepatitis B/HIV Co-Infection: A Feasibility Study.

Switching Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide Fumarate (TAF) in Hepatitis B/HIV Co-Infection: A Feasibility Study.

Journal: Clinical therapeutics
Published: September 13, 2023

Managing mpox using a remote monitoring service.

Managing mpox using a remote monitoring service.

Journal: The Journal of infection
Published: May 17, 2023

Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series.

Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series.

Journal: Lancet (London, England)
Published: October 21, 2022

COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2.

COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2.

Journal: EClinicalMedicine
Published: September 26, 2022
Showing 1-12 of 20

Last Updated: 09/26/2026